Focal atrophy and cerebrovascular disease increase dementia risk among cognitively normal older adults

Journal of Neuroimaging

Volumn 17, Issue 2, 2007, Pages 148-155

  Rosano, Caterina ^a,e   Aizenstein, Howard J ^b   Wu, Minjie ^b   Newman, Anne B ^a   Becker, James T ^c   Lopez, Oscar L ^d   Kuller, Lewis H ^a,d  

^a UNIVERSITY OF PITTSBURGH GRADUATE SCHOOL OF PUBLIC HEALTH   (United States)

^b UNIVERSITY OF PITTSBURGH   (United States)

^c UNIVERSITY OF PITTSBURGH   (United States)

^d UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

^e NONE   (United States)

Author keywords

Dementia; Focal atrophy; Hyperintensity; White matter

Indexed keywords

AGED; ALZHEIMER DISEASE; ARTICLE; BRAIN ATROPHY; BRAIN INFARCTION; CEREBROVASCULAR DISEASE; COGNITION; CONFIDENCE INTERVAL; CONTROLLED STUDY; FEMALE; FOLLOW UP; HUMAN; MALE; NUCLEAR MAGNETIC RESONANCE IMAGING;

AGED; ALZHEIMER DISEASE; ANALYSIS OF VARIANCE; ATROPHY; CEREBROVASCULAR DISORDERS; COGNITION; FEMALE; HUMANS; LOGISTIC MODELS; LONGITUDINAL STUDIES; MAGNETIC RESONANCE IMAGING; MALE; RISK FACTORS; TEMPORAL LOBE; UNITED STATES;

EID: 34247210248     PISSN: 10512284     EISSN: 15526569     Source Type: Journal    
DOI: 10.1111/j.1552-6569.2007.00093.x     Document Type: Article

References (43)

1. Kuller LH, Lopez OL, et al. Risk factors for dementia in the cardiovascular health cognition study. Neuroepidemiology 2003;22:13-22.
2. Scheltens P, Korf ES. Contribution of neuroimaging in the diagnosis of Alzheimer's disease and other dementias. Curr Opin Neurobiol 2000;13:391-396.
3. De Leon MJ, DeSanti S, et al. MRI and CSF studies in the early diagnosis of Alzheimer's disease. J Intern Med 2004;256:205-223.
4. Chetelat G, Baron JC. Early diagnosis of Alzheimer's disease: contribution of structural neuroimaging. Neuroimage 2003;18:525-541.
5. Erkinjuntti T, Lee DH, et al. Temporal lobe atrophy on magnetic resonance imaging in the diagnosis of early Alzheimer's disease. Arch Neurol 1993;50:305-310.
6. Braak H, Braak E, et al. Staging of Alzheimer-related cortical destruction. Eur Neurol 1993;33:403-408.
7. Thompson PM, Hayashi KM, et al. Dynamics of gray matter loss in Alzheimer's disease. J Neurosci 2003;23:994-1005.
8. Baron JC, Chetelat G, et al. In vivo mapping of gray matter loss with voxel-based morphometry in mild Alzheimer's disease. Neuroimage 2001;14:298-309.
9. Stoub TR, Bulgakova M, et al. MRI predictors of risk of incident Alzheimer disease: a longitudinal study. Neurology 2005;64:1520-1524.
10. Convit A, de Asis J, et al. Atrophy of the medial occipitotemporal, inferior, and middle temporal gyri in non-demented elderly predict decline to Alzheimer's disease. Neurobiol Aging 2000;21:19-26.
11. Schmidt R, Ropele S, et al. White matter lesion progression, brain atrophy, and cognitive decline: the Austrian stroke prevention study. Ann Neurol 2005;58:610-616.
12. Kuller LH, Lopez OL, et al. Risk factors for dementia in the cardiovascular health cognition study. Neuroepidemiology 2003;22:13-22.
13. den Heijer T, Geerlings MI, et al. Use of hippocampal and amygdalar volumes on magnetic resonance imaging to predict dementia in cognitively intact elderly people. Arch Gen Psychiatry 2006;63:57-62.
14. van der Flier WM, van Straaten EC, et al. LADIS study group. Medial temporal lobe atrophy and white matter hyperintensities are associated with mild cognitive deficits in non-disabled elderly people: the LADIS study. J Neurol Neurosurg Psychiatry 2005;76:1497-1500.
15. Wu CC, Mungas D, et al. Brain structure and cognition in a community sample of elderly Latinos. Neurology 2002;59:383-391.
16. van der Flier WM, Middlekoop HA, et al. Interaction of medial temporal lobe atrophy and white matter hyperintensities in AD. Neurology 2004;62:1862-1864.
17. Fried LP, Borhani NO, et al. The Cardiovascular Health Study: design and rationale. Ann Epidemiol 1991;1:263-276.
18. Lopez OL, Kuller LH, et al. Evaluations of AD in the cardiovascular health cognition study. Neuroepidemiology 2003;22:1-12.
19. Lopez OL, Kuller LH, et al. Classification of vascular dementia in the Cardiovascular Health Study Cognition Study. Neurology 2005;64:1539-1547.
20. Lopez OL, Jagust WJ, et al. Prevalence and classification of mild cognitive impairment in the Cardiovascular Health Study Cognition Study: part 1. Arch Neurol 2003;60:1385-1389.
21. Teng EL, Chui HC. The Modified Mini-Mental State (3MS) examination. J Clin Psychiatry 1987;48:314-318.
22. McKhann G, Drachman D, et al. Clinical diagnosis of Alzheimer's disease: report of the NINCDS-ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer's Disease. Neurology 1984;34:939-944.
23. Xu WL, Qui CX, Wahlin A, Winblad B, Fratiglioni L. Diabetes mellitus and risk of dementia in the Kungsholmen project: a 6-year follow-up study. Neurology 2004;63:1181-1186.
24. Moroney JT, Tang M-X, Berglund L, et al. Low-density lipoprotein cholesterol and the risk of dementia with stroke. JAMA 1999;282:254-260.
25. Bryan RN, Manolio TA, et al. A method for using MR to evaluate the effects of cardiovascular disease on the brain: the cardiovascular health study. AJNR Am J Neuroradiol 1994;15:1625-1633.
26. Yue NC, Arnold AM, et al. Sulcal, ventricular, and white matter changes at MR imaging in the aging brain: data from the cardiovascular health study. Radiology 1997;202:33-39.
27. Rosano C, Becker J, et al. Morphometric analysis of gray matter volume in demented older adults: exploratory analysis of the cardiovascular health study brain MRI database. Neuroepidemiology 2005;24:221-229.
28. Tzourio-Mazoyer N, Landeau B, et al. Automated anatomical labeling of activations in SPM using a macroscopic anatomical parcellation of the MNI MRI single-subject brain. Neuroimage 2002;15:273-289.
29. Carmichael OT, Aizenstein HJ, et al. Atlas-based hippocampus segmentation in Alzheimer's disease and mild cognitive impairment. Neuroimage 2005;27:979-990.
30. Wu M, Carmichael O, et al. Quantitative comparison of AIR, SPM, and fully deformable registration for atlas-based segmentation of functional and structural MR Images 2006. Hum. Brain Map. 27(9):747-754.
31. Ives DG, Fitzpatrick AL, et al. Surveillance and ascertainment of cardiovascular events. The Cardiovascular Health Study. Ann Epidemiol 1995;5:278-285.
32. Dufouil C, Chalmers J, et al. Effects of blood pressure lowering on cerebral white matter hyperintensities in patients with stroke: the PROGRESS (perindopril protection against recurrent stroke study) Magnetic Resonance Imaging Substudy. Circulation 2005;112:1644-1650.
33. de Leeuw FE, De Groot CJ, et al. Hypertension and cerebral white matter lesions in a prospective cohort study. Brain 2002;125:765-772.
34. Waldstein SR, Giggey PP, et al. Nonlinear relations of blood pressure to cognitive function: the Baltimore Longitudinal Study of Aging. Hypertension 2005;45:374-379.
35. Forette FM, Seux ML, et al. Prevention of dementia in randomized double-blind placebo-controlled Systolic Hypertension in Europe (Syst-Eur) trial. Lancet 1998;52(9137):1347-1351.
36. Bigler ED, Kerr B, et al. White matter lesions, quantitative magnetic resonance imaging, and dementia. Alzheimer Dis Assoc Disord 2002;16:161-170.
37. Mungas D, Reed BR, et al. Volumetric MRI predicts rate of cognitive decline related to AD and cerebrovascular disease. Neurology 2002;59:867-873.
38. Mungas D, Harvey D, et al. Longitudinal volumetric MRI change and rate of cognitive decline. Neurology 2005;65:565-571.
39. Mungas D, et al. MRI predictors of cognition in subcortical ischemic vascular disease and Alzheimer's disease. Neurology 2001;57:2229-2235.
40. van der Flier WM, van Straaten EC, et al. Small vessel disease and general cognitive function in nondisabled elderly: the LADIS study. Stroke 2005;36:2116-2120.
41. Bartzokis G. Age-related myelin breakdown: a developmental model of cognitive decline and Alzheimer's disease. Neurobiol Aging 2004;25:5-18.
42. Thompson PMHK, De Zubicaray GI, et al. Mapping hippocampal and ventricular change in Alzheimer disease. Neuroimage 2004;22:1754-1766.
43. Bell-Mc Ginty S, Lopez OL, Meltzer CC, Scanlon JM, Whyte EM, Dekosky ST, Becker JT. Differential cortical atrophy in subgroups of mild cognitive impairment. Arch Neurol 2005;62:1393-1397.